Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1997;108:111–126.

The Gordon Wilson Lecture. Decade of the brain: advances and hopes at the midpoint.

G S Oxford 1
PMCID: PMC2376583  PMID: 9108671

Full text

PDF
109

Images in this article

117Fig. 1
on p.117
118Fig. 2
on p.118

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeliovich A., Chen C., Goda Y., Silva A. J., Stevens C. F., Tonegawa S. Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell. 1993 Dec 31;75(7):1253–1262. doi: 10.1016/0092-8674(93)90613-u. [DOI] [PubMed] [Google Scholar]
  2. Anderson M. S., Kunkel L. M. The molecular and biochemical basis of Duchenne muscular dystrophy. Trends Biochem Sci. 1992 Aug;17(8):289–292. doi: 10.1016/0968-0004(92)90437-e. [DOI] [PubMed] [Google Scholar]
  3. Andreasen N. C., Arndt S., Swayze V., 2nd, Cizadlo T., Flaum M., O'Leary D., Ehrhardt J. C., Yuh W. T. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 1994 Oct 14;266(5183):294–298. doi: 10.1126/science.7939669. [DOI] [PubMed] [Google Scholar]
  4. Brewster W. K., Nichols D. E., Riggs R. M., Mottola D. M., Lovenberg T. W., Lewis M. H., Mailman R. B. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. J Med Chem. 1990 Jun;33(6):1756–1764. doi: 10.1021/jm00168a034. [DOI] [PubMed] [Google Scholar]
  5. Buchsbaum M. S., Someya T., Teng C. Y., Abel L., Chin S., Najafi A., Haier R. J., Wu J., Bunney W. E., Jr PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 1996 Feb;153(2):191–199. doi: 10.1176/ajp.153.2.191. [DOI] [PubMed] [Google Scholar]
  6. Crocq M. A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., Collier D., Lannfelt L., Sokoloff P., Schwartz J. C. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 1992 Dec;29(12):858–860. doi: 10.1136/jmg.29.12.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dani J. W., Chernjavsky A., Smith S. J. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron. 1992 Mar;8(3):429–440. doi: 10.1016/0896-6273(92)90271-e. [DOI] [PubMed] [Google Scholar]
  8. De Keyser J., Claeys A., De Backer J. P., Ebinger G., Roels F., Vauquelin G. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett. 1988 Aug 31;91(2):142–147. doi: 10.1016/0304-3940(88)90758-6. [DOI] [PubMed] [Google Scholar]
  9. Einhorn L. C., Gregerson K. A., Oxford G. S. D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording. J Neurosci. 1991 Dec;11(12):3727–3737. doi: 10.1523/JNEUROSCI.11-12-03727.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Einhorn L. C., Oxford G. S. Guanine nucleotide binding proteins mediate D2 dopamine receptor activation of a potassium channel in rat lactotrophs. J Physiol. 1993 Mar;462:563–578. doi: 10.1113/jphysiol.1993.sp019569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furth P. A., St Onge L., Böger H., Gruss P., Gossen M., Kistner A., Bujard H., Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9302–9306. doi: 10.1073/pnas.91.20.9302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gao J. H., Parsons L. M., Bower J. M., Xiong J., Li J., Fox P. T. Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science. 1996 Apr 26;272(5261):545–547. doi: 10.1126/science.272.5261.545. [DOI] [PubMed] [Google Scholar]
  13. Giros B., Jaber M., Jones S. R., Wightman R. M., Caron M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996 Feb 15;379(6566):606–612. doi: 10.1038/379606a0. [DOI] [PubMed] [Google Scholar]
  14. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A., van Ommen G. J., Galjaard H. Characterization and localization of the Huntington disease gene product. Hum Mol Genet. 1993 Dec;2(12):2069–2073. doi: 10.1093/hmg/2.12.2069. [DOI] [PubMed] [Google Scholar]
  15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996 Oct 4;274(5284):99–102. doi: 10.1126/science.274.5284.99. [DOI] [PubMed] [Google Scholar]
  16. Karni A., Tanne D., Rubenstein B. S., Askenasy J. J., Sagi D. Dependence on REM sleep of overnight improvement of a perceptual skill. Science. 1994 Jul 29;265(5172):679–682. doi: 10.1126/science.8036518. [DOI] [PubMed] [Google Scholar]
  17. Kim S. G., Uğurbil K., Strick P. L. Activation of a cerebellar output nucleus during cognitive processing. Science. 1994 Aug 12;265(5174):949–951. doi: 10.1126/science.8052851. [DOI] [PubMed] [Google Scholar]
  18. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 1991 Sep 5;353(6339):43–48. doi: 10.1038/353043a0. [DOI] [PubMed] [Google Scholar]
  19. Kotrla K. J., Weinberger D. R. Brain imaging in schizophrenia. Annu Rev Med. 1995;46:113–122. doi: 10.1146/annurev.med.46.1.113. [DOI] [PubMed] [Google Scholar]
  20. Lester H. A., Dascal N. Potassium channels. The response to vagusstoff. Nature. 1993 Aug 26;364(6440):758–759. doi: 10.1038/364758a0. [DOI] [PubMed] [Google Scholar]
  21. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995 Aug 18;269(5226):973–977. doi: 10.1126/science.7638622. [DOI] [PubMed] [Google Scholar]
  22. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A., Weber J. L., Bird T. D., Schellenberg G. D. A familial Alzheimer's disease locus on chromosome 1. Science. 1995 Aug 18;269(5226):970–973. doi: 10.1126/science.7638621. [DOI] [PubMed] [Google Scholar]
  23. Magee J. C., Johnston D. Synaptic activation of voltage-gated channels in the dendrites of hippocampal pyramidal neurons. Science. 1995 Apr 14;268(5208):301–304. doi: 10.1126/science.7716525. [DOI] [PubMed] [Google Scholar]
  24. Moises H. W., Gelernter J., Giuffra L. A., Zarcone V., Wetterberg L., Civelli O., Kidd K. K., Cavalli-Sforza L. L., Grandy D. K., Kennedy J. L. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991 Jul;48(7):643–647. doi: 10.1001/archpsyc.1991.01810310061011. [DOI] [PubMed] [Google Scholar]
  25. Mottola D. M., Brewster W. K., Cook L. L., Nichols D. E., Mailman R. B. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist. J Pharmacol Exp Ther. 1992 Jul;262(1):383–393. [PubMed] [Google Scholar]
  26. Persico A. M., Wang Z. W., Black D. W., Andreasen N. C., Uhl G. R., Crowe R. R. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatry. 1995 Jan;152(1):134–136. doi: 10.1176/ajp.152.1.134. [DOI] [PubMed] [Google Scholar]
  27. Rendt J., Oxford G. S. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats. Endocrinology. 1994 Aug;135(2):501–508. doi: 10.1210/endo.135.2.8033799. [DOI] [PubMed] [Google Scholar]
  28. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
  29. Schuman E. M., Madison D. V. Locally distributed synaptic potentiation in the hippocampus. Science. 1994 Jan 28;263(5146):532–536. doi: 10.1126/science.8290963. [DOI] [PubMed] [Google Scholar]
  30. Seeman P., Van Tol H. H. Dopamine receptor pharmacology. Trends Pharmacol Sci. 1994 Jul;15(7):264–270. doi: 10.1016/0165-6147(94)90323-9. [DOI] [PubMed] [Google Scholar]
  31. Slesinger P. A., Patil N., Liao Y. J., Jan Y. N., Jan L. Y., Cox D. R. Functional effects of the mouse weaver mutation on G protein-gated inwardly rectifying K+ channels. Neuron. 1996 Feb;16(2):321–331. doi: 10.1016/s0896-6273(00)80050-1. [DOI] [PubMed] [Google Scholar]
  32. Sokoloff P., Giros B., Martres M. P., Andrieux M., Besancon R., Pilon C., Bouthenet M. L., Souil E., Schwartz J. C. Localization and function of the D3 dopamine receptor. Arzneimittelforschung. 1992 Feb;42(2A):224–230. [PubMed] [Google Scholar]
  33. Spruston N., Schiller Y., Stuart G., Sakmann B. Activity-dependent action potential invasion and calcium influx into hippocampal CA1 dendrites. Science. 1995 Apr 14;268(5208):297–300. doi: 10.1126/science.7716524. [DOI] [PubMed] [Google Scholar]
  34. Werner P., Hussy N., Buell G., Jones K. A., North R. A. D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol. 1996 Apr;49(4):656–661. [PubMed] [Google Scholar]
  35. Wickman K. D., Iñiguez-Lluhl J. A., Davenport P. A., Taussig R., Krapivinsky G. B., Linder M. E., Gilman A. G., Clapham D. E. Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel. Nature. 1994 Mar 17;368(6468):255–257. doi: 10.1038/368255a0. [DOI] [PubMed] [Google Scholar]
  36. Wilson M. A., McNaughton B. L. Reactivation of hippocampal ensemble memories during sleep. Science. 1994 Jul 29;265(5172):676–679. doi: 10.1126/science.8036517. [DOI] [PubMed] [Google Scholar]
  37. Zhang M., Creese I. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci Lett. 1993 Oct 29;161(2):223–226. doi: 10.1016/0304-3940(93)90299-z. [DOI] [PubMed] [Google Scholar]
  38. Zhou L. W., Zhang S. P., Qin Z. H., Weiss B. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. J Pharmacol Exp Ther. 1994 Feb;268(2):1015–1023. [PubMed] [Google Scholar]
  39. de Belleroche J., Orrell R., King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet. 1995 Nov;32(11):841–847. doi: 10.1136/jmg.32.11.841. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES